Safety profile of gefitinib in advanced non-small cell lung cancer elderly patients with chronic renal failure: Two clinical cases

Lung Cancer

Volumn 47, Issue 3, 2005, Pages 421-423

  Rossi, Antonio ^a   Maione, Paolo ^a   Del Gaizo, Filomena ^a   Guerriero, Ciro ^a   Castaldo, Vincenzo ^a   Gridelli, Cesare ^a  

^a S G MOSCATI HOSPITAL   (Italy)

Author keywords

Chronic renal failure; Elderly; Gefitinib; Non small cell lung cancer

Indexed keywords

GEFITINIB;

ADVANCED CANCER; AGED; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; KIDNEY DYSFUNCTION; LUNG ADENOCARCINOMA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN TOXICITY; TREATMENT OUTCOME;

EID: 13844272813     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.09.002     Document Type: Article

References (9)

1. D.G. Pfister, D.H. Johnson, C.G. Azzoli, V. Sause, T.J. Smith, and S. Baker Jr American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003 22 2004 330 353
2. C. Gridelli, F. Perrone, C. Gallo, S. Cigolari, A. Rossi, and F. Piantedosi Chemotherapy for elderly patients with advanced non small cell lung cancer. The MILES (Multicenter Italian Lung cancer in the Elderly Study) phase 3 randomized trial J Natl Cancer Inst. 95 2003 362 372
3. D.H. Johnson Gefitinib (Iressa) trials in non-small cell lung cancer Lung Cancer 41 Suppl 1 2003 S23 S28
4. M. Fukuoka, S. Yano, G. Giaccone, T. Tamura, K. Nagakawa, and J.-Y. Douillard Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer J Clin Oncol. 21 2003 2237 2246
5. M.G. Kris, B.R. Natale, R.S. Herbst, T.J. Lynch, D. Prager, and C.P. Belani Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial JAMA 290 2003 2149 2158
6. R. Stahel, A. Rossi, L. Petruzelka, P. Kosmidis, F. de Braud, and M.M. Bernardo Lessons from the "Iressa" Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations Br J Cancer 89 Suppl 2 2003 S19 S23
7. C. Gridelli, P. Maione, V. Castaldo, and A. Rossi Gefitinib in elderly and unfit patients affected by advanced non-small cell lung cancer Br J Cancer 89 2003 1827 1829
8. D.W. Cockroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
9. M. Yoshimura, F. Imamura, K. Ueno, and S. Yamamto Severe myelotoxicity in a combination of gefitinib and vinorelbine Lung Cancer 45 2004 121 123